Web Analytics

3 Latest Announced Rounds

  • $8,000,000
    Seed

    4 Investors

    Technology, Information and Internet
    Jul 25th, 2025
  • $6,000,000
    Seed

    3 Investors

    Software Development
    Jul 25th, 2025
  • $4,300,000
    Seed

    1 Investors

    Computer & Network Security
    Jul 25th, 2025
$2,072.63M Raised in 62 Funding Rounds in the past 7 Days - View All

Funding Round Profile

AusperBio

start up
United States - San Mateo, California
  • 16/07/2024
  • Series A
  • $37,000,000

AusperBio is a clinical-stage biopharmaceutical company with operations in the USA and China, dedicated to advancing oligonucleotide and targeted delivery technologies for transformative therapies, with an initial focus on curing chronic hepatitis B. The company has developed a proprietary Med-OligoTM ASO platform with novel insights into ASO design and capabilities to substantially enhance the current ASO therapeutics. Combining with efficient targeted delivery conjugation technologies, the modular Med-OligosTM Platform empowers ASO therapeutics to treat broad viral infections, metabolic conditions, genetic disorders, and immune diseases.


Related People

Guofeng ChengCo Founder

Guofeng Cheng United States - San Mateo, California

N/A